News Headlines


Alli Diet Pill from GlaxoSmithKline Starts Taking Pre-Orders

Orlistat is the first weight loss drug approved by the Food and Drug Administration for sale in the US as an over the counter (OTC) product. GSK Consumer Healthcare will market the OTC orlistat version under the brand name alli™ (pronounced AL-eye). The Alli diet product is a fat blocker the prevents the body from absorbing excess dietary fat.

May 09, 2007 - Tampa, FL - “With the launch of the upcoming diet product Alli from GlaxoSmithKline, many retailers and online merchants are getting ready for the planned $150 million dollar ad blitz that is planned for the weight loss drug. Alli is a lower dose version of Xenical, which is a prescription diet drug made and sold by Roche.”

The initial alli package will include Welcome and Companion Guides, a Guide to Healthy Eating, a Daily Journal, a Calorie and Fat Counter, Quick Fact Cards, and free online access to a diet plan. “Our vision is to change the way people think about weight loss,” said Steven L. Burton, vice president for weight control at the GlaxoSmithKline consumer health care division in Pittsburgh.

“People are really fed up because they are bombarded with hyped products, fad diets, that overpromise and underdeliver,” Mr. Burton said. “Alli breaks through the clutter with straight talk, an honest voice, saying that losing weight is hard work.”

GlaxoSmithKline is the first one to say that Alli is not a magic bullet when it comes to weight loss. To be successful, consumers need to understand that they must take part in a regular exercise program, and have good eating habits.

Due to the increased media coverage and interest in the Alli diet product, intial supplies may be limited for the first few months. To make sure that eager consumers are able to try out the product as soon as it is available some sites have begun taking pre-orders. If you would like to place a preorder for alli, go to www.FatBlocker.biz

About GlaxoSmithKline
Is one of the world’s leading research-based pharmaceutical and healthcare companies — is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.

About GlaxoSmithKline Consumer Healthcare
GSK Consumer Healthcare is one of the world’s largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette®, NicoDerm® CQ and Commit® as well as many medicine cabinet staples, including Abreva®, Aquafresh®, Sensodyne,® Tums® and Breathe Right®.


* These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

This website (www.FatBlocker.biz) is a non-affiliated and independent informational product review site, focused on the trademarked product Alli. Alli is the OTC (over the counter) version of the prescription drug Xenical also known as orlistat, which is being marketed by GSK (GlaxoSmithKline). The information and graphics presented on this website, are not intended to infringe on GlaxoSmithKline's trademarks.
Please consult with your doctor before starting any diet, supplement, or exercise program.